CYTUNE PHARMA

Organization

Nantes Cedex 3, FR

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
IL-15/IL-15Ralpha based conjugates purification method
- Patent number 12,060,407
- Issue date Aug 13, 2024
- Cytune Pharma
- David Bechard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-15 and IL-15R\alpha sushi domain based immunocytokines
- Patent number 11,753,454
- Issue date Sep 12, 2023
- Cytune Pharma
- Sebastien Daniel Morisseau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine derived treatment with reduced vascular leak syndrome
- Patent number 11,401,312
- Issue date Aug 2, 2022
- Cytune Pharma
- David Bechard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-15 and IL-15RAPLHA sushi domain based immunocytokines
- Patent number 11,273,204
- Issue date Mar 15, 2022
- Cytune Pharma
- Alain Gey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-15 and IL-15Rα sushi domain based immunocytokines
- Patent number 10,899,816
- Issue date Jan 26, 2021
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Sebastien Daniel Morisseau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-15/IL-15Ralpha based conjugates purification method
- Patent number 10,808,022
- Issue date Oct 20, 2020
- Cytune Pharma
- David Bechard
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
IL-15 and IL-15R\alpha sushi domain based immunocytokines
- Patent number 10,626,155
- Issue date Apr 21, 2020
- Cytune Pharma
- Sebastien Daniel Morisseau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGA...
- Publication number 20240350589
- Publication date Oct 24, 2024
- CYTUNE PHARMA
- Lenka Kyrych Sadilkova
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-15 BASED IMMUNOCYTOKINES
- Publication number 20240294594
- Publication date Sep 5, 2024
- CYTUNE PHARMA
- Irena Adkins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-15 AND IL-15R\ALPHA SUSHI DOMAIN BASED IMMUNOCYTOKINES
- Publication number 20240083963
- Publication date Mar 14, 2024
- CYTUNE PHARMA
- Sebastien Daniel Morisseau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER
- Publication number 20230398185
- Publication date Dec 14, 2023
- CYTUNE PHARMA
- Stefano FERRARA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING SQUAMOUS CELL CARCINOMA
- Publication number 20230390361
- Publication date Dec 7, 2023
- CYTUNE PHARMA
- Stefano FERRARA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME
- Publication number 20230183306
- Publication date Jun 15, 2023
- CYTUNE PHARMA
- David Bechard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2/IL-15R BETA GAMMA AGONIST DOSING REGIMENS FOR TREATING CANCER...
- Publication number 20220241375
- Publication date Aug 4, 2022
- CYTUNE PHARMA
- Ulrich MOEBIUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PHARMACEUTICAL COMPOSITION
- Publication number 20220202904
- Publication date Jun 30, 2022
- CYTUNE PHARMA
- David Bechard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-15 AND IL-15RALPHA SUSHI DOMAIN BASED MODULOKINES
- Publication number 20220193199
- Publication date Jun 23, 2022
- CYTUNE PHARMA
- Alain GEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINED PHARMACEUTICAL COMPOSITION
- Publication number 20220168395
- Publication date Jun 2, 2022
- CYTUNE PHARMA
- David Bechard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-15 AND IL-15R\ALPHA SUSHI DOMAIN BASED IMMUNOCYTOKINES
- Publication number 20210147503
- Publication date May 20, 2021
- CYTUNE PHARMA
- Sebastien Daniel Morisseau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-15/IL-15RALPHA BASED CONJUGATES PURIFICATION METHOD
- Publication number 20210009658
- Publication date Jan 14, 2021
- CYTUNE PHARMA
- David Bechard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-15 AND IL-15R\ALPHA SUSHI DOMAIN BASED IMMUNOCYTOKINES
- Publication number 20180312560
- Publication date Nov 1, 2018
- CYTUNE PHARMA
- Sebastien Daniel MORISSEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED PHARMACEUTICAL COMPOSITION
- Publication number 20160184399
- Publication date Jun 30, 2016
- CYTUNE PHARMA
- David BECHARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-15 AND IL-15RAPLHA SUSHI DOMAIN BASED MODULOKINES
- Publication number 20160175459
- Publication date Jun 23, 2016
- CYTUNE PHARMA
- Alain GEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME
- Publication number 20160068584
- Publication date Mar 10, 2016
- CYTUNE PHARMA
- David Bechard
- C07 - ORGANIC CHEMISTRY

CYTUNE PHARMA

Organization

Patents Grantslast 30 patents

IL-15/IL-15Ralpha based conjugates purification method

IL-15 and IL-15R\alpha sushi domain based immunocytokines

Cytokine derived treatment with reduced vascular leak syndrome

IL-15 and IL-15RAPLHA sushi domain based immunocytokines

IL-15 and IL-15Rα sushi domain based immunocytokines

IL-15/IL-15Ralpha based conjugates purification method

IL-15 and IL-15R\alpha sushi domain based immunocytokines

Patents Applicationslast 30 patents

IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGA...

INTERLEUKIN-15 BASED IMMUNOCYTOKINES

IL-15 AND IL-15R\ALPHA SUSHI DOMAIN BASED IMMUNOCYTOKINES

IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER

IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING SQUAMOUS CELL CARCINOMA

CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME

IL-2/IL-15R BETA GAMMA AGONIST DOSING REGIMENS FOR TREATING CANCER...

COMBINED PHARMACEUTICAL COMPOSITION

IL-15 AND IL-15RALPHA SUSHI DOMAIN BASED MODULOKINES

COMBINED PHARMACEUTICAL COMPOSITION

IL-15 AND IL-15R\ALPHA SUSHI DOMAIN BASED IMMUNOCYTOKINES

IL-15/IL-15RALPHA BASED CONJUGATES PURIFICATION METHOD

IL-15 AND IL-15R\ALPHA SUSHI DOMAIN BASED IMMUNOCYTOKINES

COMBINED PHARMACEUTICAL COMPOSITION

IL-15 AND IL-15RAPLHA SUSHI DOMAIN BASED MODULOKINES

CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME

Trademarklast 30 trademarks